Your session is about to expire
← Back to Search
Liquid Biopsy for Lung Cancer
Study Summary
This trial is testing how well cell-free DNA liquid biopsy works in screening high-risk patients for lung cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Am I a suitable candidate to participate in this research?
"This clinical trial seeks 100 participants diagnosed with lung cancer, aged between 50 and 80. In order to qualify for the study, patients must have a documented written informed consent, smoking history of at least 20 pack-years (or quit within 15 years), be referred for counseling regarding Lung Cancer Screening Tests that their health insurance can cover, agree to provide blood samples in English language and sign off on undergoing either Liquid Biopsy or LDCT screening."
Does the enrollment criteria for this trial encompass individuals aged 45 and above?
"This research initiative is recruiting participants over the age of 50 and below 80 years old."
How many volunteers are eligible to be part of this experiment?
"Affirmative. Per the info hosted on clinicaltrials.gov, this medical research is actively seeking participants with a goal of recruiting 100 patients from 1 location. The study was initially published on July 29th 2022 and its most recent update came August 15th 2022."
Are individuals still able to partake in this experimentation?
"Affirmative. According to the clinicaltrials.gov listing, this medical trial is actively recruiting. It was posted on July 29th 2022 and has been edited as recently as August 15th of the same year. The study needs 100 participants from 1 site in order to complete enrolment."
Share this study with friends
Copy Link
Messenger